Search Results - "Van de Velde, C J"

Neoadjuvant chemotherapy for operable breast cancer by Mieog, J. S. D., van der Hage, J. A., van de Velde, C. J. H.

“…Background: Neoadjuvant chemotherapy for early breast cancer can avoid mastectomy by shrinkage of tumour volume. This review assesses the effectiveness of…”
Get full text

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854) by Dekker, T. J. A., van de Velde, C. J. H., van Pelt, G. W., Kroep, J. R., Julien, J-P., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Mesker, W. E.

“…The tumor-stroma ratio has previously been shown to be prognostic for patients with invasive breast cancer. We present a validation study to assess the…”
Get full text

Differences in outcomes of oesophageal and gastric cancer surgery across Europe by Dikken, J. L., van Sandick, J. W., Allum, W. H., Johansson, J., Jensen, L. S., Putter, H., Coupland, V. H., Wouters, M. W. J. M., Lemmens, V. E. P., van de Velde, C. J. H.

“…Background: In several European countries, centralization of oesophagogastric cancer surgery has been realized and clinical audits initiated. The present study…”
Get full text

Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis by de Glas, N. A., Kiderlen, M., Bastiaannet, E., de Craen, A. J. M., van de Water, W., van de Velde, C. J. H., Liefers, G. J.

“…Old age is associated with comorbidity and decreased functioning which influences treatment decisions in elderly breast cancer patients. The purpose of this…”
Get full text

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study by van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.

“…Tamoxifen and aromatase inhibitors are associated with side effects which can significantly impact quality of life (QoL). We assessed QoL in the Tamoxifen…”
Get full text

Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study by Sibinga Mulder, B G, Hendriks, P, Baetens, T R, van Erkel, A R, van Rijswijk, C S P, van der Meer, R W, van de Velde, C J H, Vahrmeijer, A L, Mieog, J S D, Burgmans, M C

“…Compared to surgery, radiofrequency ablation(RFA) for colorectal liver metastasis(CRLM) is associated with higher local recurrence(LR) rates. A wide margin (at…”
Get full text

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects by Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., Maartense, E., Smorenburg, C. H., Putter, H., Dieudonné, A. S., Neven, P., Van de Velde, C. J. H., Nortier, J. W. R., Guchelaar, H.-J.

“…Breast cancer patients with absent or reduced CYP2D6 activity and consequently low endoxifen levels may benefit less from tamoxifen treatment. CYP2D6 poor and…”
Get full text

Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery by Gooiker, G. A., van Gijn, W., Wouters, M. W. J. M., Post, P. N., van de Velde, C. J. H., Tollenaar, R. A. E. M.

“…Background: Many studies have shown lower mortality and higher survival rates after pancreatic surgery with high‐volume providers, suggesting that…”
Get full text

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer by van Dijk, T.H., Tamas, K., Beukema, J.C., Beets, G.L., Gelderblom, A.J., de Jong, K.P., Nagtegaal, I.D., Rutten, H.J., van de Velde, C.J., Wiggers, T., Hospers, G.A., Havenga, K.

“…To evaluate the efficacy and tolerability of preoperative short-course radiotherapy followed by capecitabine and oxaliplatin treatment in combination with…”
Get full text

Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients by Bastiaannet, E, Liefers, G. J, de Craen, A. J. M, Kuppen, P. J. K, van de Water, W, Portielje, J. E. A, van der Geest, L. G. M, Janssen-Heijnen, M. L. G, Dekkers, O. M, van de Velde, C. J. H, Westendorp, R. G. J

“…Breast cancer is the most common type of cancer in several parts of the world and the number of elderly patients is increasing. The aim of this study was to…”
Get full text

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients by Zeestraten, E C M, Reimers, M S, Saadatmand, S, Dekker, J-W T, Liefers, G J, van den Elsen, P J, van de Velde, C J H, Kuppen, P J K

“…Background: Evasion of immune surveillance and suppression of the immune system are important hallmarks of tumour development in colon cancer. The goal of this…”
Get full text

Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis by Lu, W. L., Jansen, L., Post, W. J., Bonnema, J., Van de Velde, J. C., De Bock, G. H.

“…Purpose The purpose was to establish the impact on survival of early detection of a local recurrence of breast cancer as compared to late detection. Design A…”
Get full text

Effect of preoperative chemotherapy on the histopathological classification of gastric cancer by Caspers, I. A., Biesma, H. D., Wiklund, K., Pontén, F., Lind, P., Nordsmark, M., Sikorska, K., Meershoek-KleinKranenbarg, E., Hartgrink, H. H., van de Velde, C. J. H., van Sandick, J. W., Verheij, M., Cats, A., van Grieken, N. C. T.

“…Background In the era of individualized gastric cancer (GC) treatment, accurate determination of histological subtype becomes increasingly relevant. As yet, it…”
Get full text

Impact of resection margin status on recurrence and survival in pancreatic cancer surgery by Tummers, W. S., Groen, J. V., Sibinga Mulder, B. G., Farina‐Sarasqueta, A., Morreau, J., Putter, H., van de Velde, C. J., Vahrmeijer, A. L., Bonsing, B. A., Mieog, J. S., Swijnenburg, R. J.

“…Background The prognosis of patients with pancreatic ductal adenocarcinoma (PDAC) is poor and selection of patients for surgery is challenging. This study…”
Get full text

Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery by den Dulk, M., Marijnen, C. A. M., Collette, L., Putter, H., Påhlman, L., Folkesson, J., Bosset, J.-F., Rödel, C., Bujko, K., van de Velde, C. J. H.

“…Background: The association between diverting stomas and symptomatic anastomotic leakage after rectal cancer surgery was studied, as well as the impact of…”
Get full text

Association Between the Most Frequent Complications After Surgery for Stage I–III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences by Breugom, A. J., van Dongen, D. T., Bastiaannet, E., Dekker, F. W., van der Geest, L. G. M., Liefers, G. J., Marinelli, A. W. K. S., Mesker, W. E., Portielje, J. E. A., Steup, W. H., Tseng, L. N. L., van de Velde, C. J. H., Dekker, J. W. T.

“…Background The purpose of this study was to identify the ten most frequent complications after surgery for stage I–III colon cancer and to assess the…”
Get full text

The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients by Vogelaar, F. J., Reimers, M. S., van der Linden, R. L. A., van der Linden, J. C., Smit, V. T. H. B. M., Lips, D. J., van de Velde, C. J. H., Bosscha, K.

“…Background Lymph node status in colon cancer is critical for prognosis estimation and treatment allocation. The purpose of this study was to compare the…”
Get full text

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer by Goossens-Beumer, I J, Zeestraten, E C M, Benard, A, Christen, T, Reimers, M S, Keijzer, R, Sier, C F M, Liefers, G J, Morreau, H, Putter, H, Vahrmeijer, A L, van de Velde, C J H, Kuppen, P J K

“…Background: Tumour aggressiveness might be related to the degree of main cancer hallmark acquirement of tumour cells, reflected by expression levels of…”
Get full text

Urinary dysfunction after rectal cancer treatment is mainly caused by surgery by Lange, M. M., Maas, C. P., Marijnen, C. A. M., Wiggers, T., Rutten, H. J., Kranenbarg, E. Klein, van de Velde, C. J. H.

“…Background: Urinary dysfunction (UD) is common after rectal cancer treatment, but the contribution of each treatment component (surgery and radiotherapy) to…”
Get full text

Risk factors for anastomotic failure after total mesorectal excision of rectal cancer by Peeters, K. C. M. J., Tollenaar, R. A. E. M., Marijnen, C. A. M., Klein Kranenbarg, E., Steup, W. H., Wiggers, T., Rutten, H. J., van de Velde, C. J. H.

“…Background: Anastomotic leakage is a major complication of rectal cancer surgery. The aim of this study was to investigate risk factors associated with…”
Get full text